Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
57m agoFirst Horizon Announces Tyler Craft Named to the Triangle Business Journal 2026 40 Under 40
1h agoSuper Micro Computer, Inc. Investors Have Until May 26th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff Role
1h agoAlcoa Corporation Announces $65 Million Capital Investment in Mosjøen
1h agoOwlet Expands ANZ Product Suite with Launch of Dream Sight™ and Dream Duo™ 3, Bringing the World’s Most Comprehensive Baby Monitoring System to More Families
1h agoUNITED HOMES LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Stockholders that a Class Action Lawsuit Has Been Filed Against United Homes Group, Inc. and Encourages Investors to Contact the Firm
Pmv Pharmaceuticals, Inc. logo

Pmv Pharmaceuticals, Inc.

About

Pmv Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
PMV Pharmaceuticals Announces Board Chair Transition
Mar 6 2026
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Feb 26 2026
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
Nov 12 2025
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights
Oct 24 2025
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

Community Chat

Ask AI

6ix6ixAIEvents